These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update. Tajti J; Szok D; Csáti A; Vécsei L Curr Pain Headache Rep; 2016 Jan; 20(1):1. PubMed ID: 26695061 [TBL] [Abstract][Full Text] [Related]
25. Cost considerations in headache treatment. Part 1: Prophylactic migraine treatment. Adelman JU; Von Seggern R Headache; 1995 Sep; 35(8):479-87. PubMed ID: 7591743 [TBL] [Abstract][Full Text] [Related]
26. [Alternatives to beta blockers in preventive migraine treatment]. Evers S Nervenarzt; 2008 Oct; 79(10):1135-6, 1138-40, 1142-3. PubMed ID: 18806984 [TBL] [Abstract][Full Text] [Related]
27. Topiramate in migraine prevention: evidence-based medicine from clinical trials. Silberstein SD Neurol Sci; 2004 Oct; 25 Suppl 3():S244-5. PubMed ID: 15549548 [TBL] [Abstract][Full Text] [Related]
28. Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action. Sprenger T; Viana M; Tassorelli C Neurotherapeutics; 2018 Apr; 15(2):313-323. PubMed ID: 29671241 [TBL] [Abstract][Full Text] [Related]
29. Prophylaxis of migraine in children and adolescents. Kacperski J Paediatr Drugs; 2015 Jun; 17(3):217-26. PubMed ID: 25792525 [TBL] [Abstract][Full Text] [Related]
30. [Sexual dysfunction in migraine patients who receive preventive treatment: identification by means of two screening tests]. Domínguez E; Ruiz L; Hernández MS; Muñoz I; Ruiz-Piñero M; Uribe F; Guerrero-Peral ÁL; Toribio-Díaz ME Rev Neurol; 2015 Jan; 60(1):10-6. PubMed ID: 25522859 [TBL] [Abstract][Full Text] [Related]
31. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial. Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025 [TBL] [Abstract][Full Text] [Related]
32. [Spanish study of quality of life in migraine (II). Profile of medication consumption and subjective efficacy]. Pascual J; Leira R; Láinez JM; Alberca R; Titus F; Morales F; Díez-Tejedor E; García de Polavieja J Neurologia; 1999 May; 14(5):204-9. PubMed ID: 10377720 [TBL] [Abstract][Full Text] [Related]
34. Effect of Prophylactic Medication on Associated Dizziness and Motion Sickness in Migraine. Lee SH; Jeong SH; Kim JS; Kim HJ; Choi KD; Choi JH; Oh SY; Park JY; Kim DU; Kim BK Otol Neurotol; 2018 Jan; 39(1):e45-e51. PubMed ID: 29227453 [TBL] [Abstract][Full Text] [Related]
35. [Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine]. Gracia-Naya M; Santos-Lasaosa S; Ríos-Gómez C; Sánchez-Valiente S; García-Gomara MJ; Latorre-Jiménez AM; Artal-Roy J; Mauri-Llerda JA Rev Neurol; 2011 Aug; 53(4):201-8. PubMed ID: 21780072 [TBL] [Abstract][Full Text] [Related]
36. Clinical advances in the preventive treatment of migraine. Mannix LK Acta Neurol Taiwan; 2004 Dec; 13(4):158-69. PubMed ID: 15666691 [TBL] [Abstract][Full Text] [Related]
37. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study). Gupta P; Singh S; Goyal V; Shukla G; Behari M Headache; 2007 Mar; 47(3):402-12. PubMed ID: 17371357 [TBL] [Abstract][Full Text] [Related]
38. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Silberstein SD; Holland S; Freitag F; Dodick DW; Argoff C; Ashman E; Neurology; 2012 Apr; 78(17):1337-45. PubMed ID: 22529202 [TBL] [Abstract][Full Text] [Related]
39. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine. Cady RK; Schreiber CP; Porter JA; Blumenfeld AM; Farmer KU Headache; 2011 Jan; 51(1):21-32. PubMed ID: 21070228 [TBL] [Abstract][Full Text] [Related]
40. [Pharmaco-epidemiological study on the prophylactic treatment of migraine. National inquiry on attitude to prescription practices by primary care physicians and neurologists in Franceø]. Lantéri-Minet M; Alchaar H; Besson G; Billé-Turc F; Bouillat J; Brudon F; Donnet A; Galletti P; Maitre M; Moene Y; Rambaud G; Rostini C; Valance J; Gastaut JL Rev Neurol (Paris); 2000 Dec; 156(12):1106-12. PubMed ID: 11139726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]